We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$370M
AUM Growth
-$21.1M
(-5.4%)
Cap. Flow
-$40.3M
Cap. Flow
% of AUM
-10.9%
Top 10 Holdings %
Top 10 Hldgs %
65.7%
Holding
48
New
–
Increased
–
Reduced
4
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Supernus Pharmaceuticals
SUPN
|
+$1.36M |
| 2 |
AGEN
Agenus
AGEN
|
+$455K |
| 3 |
RLI Corp
RLI
|
+$206K |
| 4 |
U-Haul Holding Co
UHAL
|
+$89.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 30.91% |
| 2 | Healthcare | 17.54% |
| 3 | Industrials | 17.21% |
| 4 | Financials | 7.88% |
| 5 | Technology | 4.64% |
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Bruce & Co held 48 positions worth $370M, down 5.4% from $391M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Bruce & Co withdrew a net $40.3M in Q3 2016, reducing 4 holdings. Its largest reduction was Supernus Pharmaceuticals, cutting an estimated $1.36M.
By sector, the portfolio is most concentrated in Utilities at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Industrials.
- Bruce & Co's biggest Q3 2016 reduction was Supernus Pharmaceuticals, cutting an estimated $1.36M.
- Bruce & Co's ten largest holdings make up 66% of its $370M portfolio in Q3 2016.
- Bruce & Co opened 0 new positions and closed 0 in Q3 2016.
- Bruce & Co's portfolio value fell 5.4% quarter-over-quarter to $370M.
Based on Bruce & Co's 13F filing for Q3 2016, filed 14 Nov 2016.